These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

207 related items for PubMed ID: 18540247

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Serum insulin-like growth factor I (IGF-I) and IGF-binding protein 3 levels are increased in central precocious puberty: effects of two different treatment regimens with gonadotropin-releasing hormone agonists, without or in combination with an antiandrogen (cyproterone acetate).
    Juul A, Scheike T, Nielsen CT, Krabbe S, Müller J, Skakkebaek NE.
    J Clin Endocrinol Metab; 1995 Oct; 80(10):3059-67. PubMed ID: 7559897
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Irreversible increase of serum IGF-1 and IGFBP-3 levels in GnRH-dependent precocious puberty of different etiologies: implications for the onset of puberty.
    Belgorosky A, Rivarola MA.
    Horm Res; 1998 Oct; 49(5):226-32. PubMed ID: 9568807
    [Abstract] [Full Text] [Related]

  • 7. Basal luteinizing hormone/follicle stimulating hormone ratio in diagnosis of central precocious puberty.
    Supornsilchai V, Hiranrat P, Wacharasindhu S, Srivuthana S, Aroonparkmongkol S.
    J Med Assoc Thai; 2003 Jun; 86 Suppl 2():S145-51. PubMed ID: 12929982
    [Abstract] [Full Text] [Related]

  • 8. Associations among IGF-1, IGF2, IGF-1R, IGF-2R, IGFBP-3, insulin genetic polymorphisms and central precocious puberty in girls.
    Chang HP, Yang SF, Wang SL, Su PH.
    BMC Endocr Disord; 2018 Sep 19; 18(1):66. PubMed ID: 30249230
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Ultrasound assessment of breast development: distinction between premature thelarche and precocious puberty.
    Youn I, Park SH, Lim IS, Kim SJ.
    AJR Am J Roentgenol; 2015 Mar 19; 204(3):620-4. PubMed ID: 25714294
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. The response to gonadotropin releasing hormone (GnRH) stimulation test does not predict the progression to true precocious puberty in girls with onset of premature thelarche in the first three years of life.
    Bizzarri C, Spadoni GL, Bottaro G, Montanari G, Giannone G, Cappa M, Cianfarani S.
    J Clin Endocrinol Metab; 2014 Feb 19; 99(2):433-9. PubMed ID: 24297793
    [Abstract] [Full Text] [Related]

  • 16. [The differentiation between premature thelarche and pubertas praecox on the basis of clinical, hormonal and radiological findings].
    Pohlenz J, Habermehl P, Wemme H, Grimm W, Schönberger W.
    Dtsch Med Wochenschr; 1994 Sep 30; 119(39):1301-6. PubMed ID: 7924927
    [Abstract] [Full Text] [Related]

  • 17. [Diagnostic value of baseline serum luteinizing hormone level for central precocious puberty in girls].
    Ou-Yang LX, Yang F.
    Zhongguo Dang Dai Er Ke Za Zhi; 2017 Jul 30; 19(7):729-733. PubMed ID: 28697822
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.